-
1
-
-
0020570966
-
Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals
-
Alousi A.A., Canter J.M., Montenaro M.J., Fort D.J., Ferrari R.A. Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals. J. Cardiovasc. Pharmacol. 5:1983;792-803.
-
(1983)
J. Cardiovasc. Pharmacol.
, vol.5
, pp. 792-803
-
-
Alousi, A.A.1
Canter, J.M.2
Montenaro, M.J.3
Fort, D.J.4
Ferrari, R.A.5
-
2
-
-
0018862416
-
Amrinone: A positive inotropic agent with a direct vasodilatatory activity in the canine isolated perfused hind limb preparation
-
Alousi A.A., Heltosky A. Amrinone: a positive inotropic agent with a direct vasodilatatory activity in the canine isolated perfused hind limb preparation. Fed. Proc. 39:1980;855-861.
-
(1980)
Fed. Proc.
, vol.39
, pp. 855-861
-
-
Alousi, A.A.1
Heltosky, A.2
-
3
-
-
84986486671
-
Reaction of 2-dimethylamino-methylene-1,3-diones with dinucleophiles. V. Synthesis of 5-acyl-1,2-dihydro-2-oxo-3-pyridinecarbonitriles and 1,2,5,6,7,8-hexahydro-2,5-dioxo-3-quinolinecarboxamides
-
Mosti L., Schenone P., Menozzi G. Reaction of 2-dimethylamino-methylene-1,3-diones with dinucleophiles. V. Synthesis of 5-acyl-1,2-dihydro-2-oxo-3-pyridinecarbonitriles and 1,2,5,6,7,8-hexahydro-2,5-dioxo-3-quinolinecarboxamides. J. Heterocycl. Chem. 22:1985;1503-1509.
-
(1985)
J. Heterocycl. Chem.
, vol.22
, pp. 1503-1509
-
-
Mosti, L.1
Schenone, P.2
Menozzi, G.3
-
4
-
-
0027249412
-
A pharmacological, crystallographic and quantum chemical study of new inotropic agents
-
Dorigo P., Gaion R.M., Belluco P., Fraccarollo D., Maragno I., Bombieri G., Benetollo F., Mosti L., Orsini F. A pharmacological, crystallographic and quantum chemical study of new inotropic agents. J. Med. Chem. 36:1993;2475-2484.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 2475-2484
-
-
Dorigo, P.1
Gaion, R.M.2
Belluco, P.3
Fraccarollo, D.4
Maragno, I.5
Bombieri, G.6
Benetollo, F.7
Mosti, L.8
Orsini, F.9
-
5
-
-
0030805559
-
2-Pyridone derivatives as inotropic agents: Synthesis, pharmacology and molecular modeling study
-
Mosti L., Boggia R., Fossa P. 2-Pyridone derivatives as inotropic agents: synthesis, pharmacology and molecular modeling study. Farmaco. 52:1997;331-337.
-
(1997)
Farmaco
, vol.52
, pp. 331-337
-
-
Mosti, L.1
Boggia, R.2
Fossa, P.3
-
6
-
-
0031417592
-
Inotropic agents. Synthesis and structure-activity relationships of new milrinone related cAMP PDE III inhibitors
-
Fossa P., Boggia R., Lo Presti E., Mosti L., Dorigo P., Floreani M. Inotropic agents. Synthesis and structure-activity relationships of new milrinone related cAMP PDE III inhibitors. Farmaco. 52:1997;523-530.
-
(1997)
Farmaco
, vol.52
, pp. 523-530
-
-
Fossa, P.1
Boggia, R.2
Lo Presti, E.3
Mosti, L.4
Dorigo, P.5
Floreani, M.6
-
7
-
-
0026603197
-
Antagonism towards endogenous adenosine and inhibition of cGI-PDE in the cardiac effects of amrinone, milrinone and related analogues
-
Dorigo P., Gaion R.M., Belluco P., Borea P.A., Guerra L., Mosti L., Floreani M., Carpenedo F. Antagonism towards endogenous adenosine and inhibition of cGI-PDE in the cardiac effects of amrinone, milrinone and related analogues. Gen. Pharmacol. 23:1992;535-541.
-
(1992)
Gen. Pharmacol.
, vol.23
, pp. 535-541
-
-
Dorigo, P.1
Gaion, R.M.2
Belluco, P.3
Borea, P.A.4
Guerra, L.5
Mosti, L.6
Floreani, M.7
Carpenedo, F.8
-
8
-
-
0023552639
-
Cardiotonic agents. 8. Selective inhibitors of adenosine 3′,5′-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity
-
Moos H.W., Humblet C.C., Sircar I., Rithner C., Weishaar R.E., Bristol J.A., McPhail A.T. Cardiotonic agents. 8. Selective inhibitors of adenosine 3′,5′-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity. J. Med. Chem. 30:1987;1963-1972.
-
(1987)
J. Med. Chem.
, vol.30
, pp. 1963-1972
-
-
Moos, H.W.1
Humblet, C.C.2
Sircar, I.3
Rithner, C.4
Weishaar, R.E.5
Bristol, J.A.6
McPhail, A.T.7
-
9
-
-
0023853680
-
M. Sabio, Cardiotonic agents. 3. A topographical model of the cardiac cAMP phosphodiesterase receptor
-
Erhardt P.W., Hagedorn A.A. III M. Sabio, Cardiotonic agents. 3. A topographical model of the cardiac cAMP phosphodiesterase receptor. Mol. Pharmacol. 33:1988;1-13.
-
(1988)
Mol. Pharmacol.
, vol.33
, pp. 1-13
-
-
Erhardt, P.W.1
Hagedorn A.A. III2
-
10
-
-
0032110255
-
Toward the identification of the cardiac cGMP inhibited-phosphodiesterase catalytic site
-
Fossa P., Boggia R., Mosti L. Toward the identification of the cardiac cGMP inhibited-phosphodiesterase catalytic site. J. Comput. Aided Mol. Des. 12:1998;1-12.
-
(1998)
J. Comput. Aided Mol. Des.
, vol.12
, pp. 1-12
-
-
Fossa, P.1
Boggia, R.2
Mosti, L.3
-
11
-
-
0027425372
-
Synthesis and cardiotonic activity of esters of 2-substituted 5-acetyl-1,6-dihydro-6-oxo-3-pyridinecarboxylic acids
-
Mosti L., Schenone P., Iester M., Dorigo P., Gaion R.M., Fraccarollo D. Synthesis and cardiotonic activity of esters of 2-substituted 5-acetyl-1,6-dihydro-6-oxo-3-pyridinecarboxylic acids. Eur. J. Med. Chem. 28:1993;853-858.
-
(1993)
Eur. J. Med. Chem.
, vol.28
, pp. 853-858
-
-
Mosti, L.1
Schenone, P.2
Iester, M.3
Dorigo, P.4
Gaion, R.M.5
Fraccarollo, D.6
-
12
-
-
0028316797
-
Pharmacological characterization of a new milrinone analogue
-
Dorigo P., Fraccarollo D., Santostasi G., Gaion R.M., Maragno I., Floreani M., Carpenedo F., Iester M., Mosti L., Schenone P. Pharmacological characterization of a new milrinone analogue. Farmaco. 49:1994;19-23.
-
(1994)
Farmaco
, vol.49
, pp. 19-23
-
-
Dorigo, P.1
Fraccarollo, D.2
Santostasi, G.3
Gaion, R.M.4
Maragno, I.5
Floreani, M.6
Carpenedo, F.7
Iester, M.8
Mosti, L.9
Schenone, P.10
-
13
-
-
84986524472
-
Reaction of 2-dimethylamino-methylene-1,3-diones with dinucleophiles. I. Synthesis of 1,5-disubstituted 4-acylpyrazoles
-
Schenone P., Mosti L., Menozzi G. Reaction of 2-dimethylamino-methylene-1,3-diones with dinucleophiles. I. Synthesis of 1,5-disubstituted 4-acylpyrazoles. J. Heterocycl. Chem. 19:1982;1355-1361.
-
(1982)
J. Heterocycl. Chem.
, vol.19
, pp. 1355-1361
-
-
Schenone, P.1
Mosti, L.2
Menozzi, G.3
-
14
-
-
0017237212
-
Studies on ketene and its derivatives. LXXVI. Reactions of aceto-acetamide and β-aminocrotonamide with β-diketene, β-ketoaldehyde and related compounds
-
Tetsuzo K., Masaki N. Studies on ketene and its derivatives. LXXVI. Reactions of aceto-acetamide and β-aminocrotonamide with β-diketene, β-ketoaldehyde and related compounds. Chem. Pharm. Bull. 24:1976;303-309.
-
(1976)
Chem. Pharm. Bull.
, vol.24
, pp. 303-309
-
-
Tetsuzo, K.1
Masaki, N.2
-
15
-
-
0344704609
-
The synthesis and proof of structure of 2,4-dimethyl-6-hydroxynicotinamide
-
R.E. Buckles, A. Langsjoen, L. Mueller, I. Svendsen, The synthesis and proof of structure of 2,4-dimethyl-6-hydroxynicotinamide, Proc. Minn. Acad. Sci. 26 (1958) 257-258; Chem. Abstr. 54 (1960) 24724b.
-
(1958)
Proc. Minn. Acad. Sci.
, vol.26
, pp. 257-258
-
-
Buckles, R.E.1
Langsjoen, A.2
Mueller, L.3
Svendsen, I.4
-
16
-
-
24444449295
-
-
R.E. Buckles, A. Langsjoen, L. Mueller, I. Svendsen, The synthesis and proof of structure of 2,4-dimethyl-6-hydroxynicotinamide, Proc. Minn. Acad. Sci. 26 (1958) 257-258; Chem. Abstr. 54 (1960) 24724b.
-
(1960)
Chem. Abstr.
, vol.54
-
-
-
17
-
-
0029243465
-
The matching of electrostatic extrema: A useful method in drug design? A study of phosphodiesterase III inhibitors
-
Apaya R.A., Lucchese B., Price S.L., Vinter J.G. The matching of electrostatic extrema: a useful method in drug design? A study of phosphodiesterase III inhibitors. J. Comput. Aided Mol. Des. 9:1995;33-43.
-
(1995)
J. Comput. Aided Mol. Des.
, vol.9
, pp. 33-43
-
-
Apaya, R.A.1
Lucchese, B.2
Price, S.L.3
Vinter, J.G.4
-
18
-
-
0003501442
-
-
Columbia University, New York
-
MacroModel, Version 5.5, Columbia University, New York, 1996.
-
(1996)
MacroModel, Version 5.5
-
-
-
19
-
-
0003424228
-
-
Hypercube Inc., Gainesville, FL
-
HyperChem, Release 5.0, Hypercube Inc., Gainesville, FL, 1996.
-
(1996)
HyperChem, Release 5.0
-
-
-
20
-
-
0004133516
-
-
Gaussian Inc.*Pittsburgh*PA
-
Gaussian-94 (Revision A.1), M.J. Frisch, G.W. Trucks, H.B. Schlegel, P.M.W. Gill, B.G. Johnson, M.A. Robb, J.R. Cheeseman, T.A. Keith, G.A. Petersson, J.A. Montgomery, K. Raghavachari, M.A. Al-laham, V.G. Zakrzewski, J.V. Ortiz, J.B. Foresman, J. Cioslowski, B.B. Stefanov, A. Nanayakkara, M. Challacombe, C.Y. Peng, P.Y. Ayala, W. Chen, M.W. Wong, J.L. Andres, E.S. Replogle, R. Gomperts, R.L. Martin, D.J. Fox, J.S. Binkley, D.J. Defrees, J. Baker, J.P. Stewart, M. Head-Gordon, C. Gonzalez, J.A. Pople, Gaussian Inc., Pittsburgh, PA, 1995.
-
(1995)
Gaussian-94 (Revision A.1)
-
-
Frisch, M.J.1
Trucks, G.W.2
Schlegel, H.B.3
Gill, P.M.W.4
Johnson, B.G.5
Robb, M.A.6
Cheeseman, J.R.7
Keith, T.A.8
Petersson, G.A.9
Montgomery, J.A.10
Raghavachari, K.11
Al-Laham, M.A.12
Zakrzewski, V.G.13
Ortiz, J.V.14
Foresman, J.B.15
Cioslowski, J.16
Stefanov, B.B.17
Nanayakkara, A.18
Challacombe, M.19
Peng, C.Y.20
Ayala, P.Y.21
Chen, W.22
Wong, M.W.23
Andres, J.L.24
Replogle, E.S.25
Gomperts, R.26
Martin, R.L.27
Fox, D.J.28
Binkley, J.S.29
Defrees, D.J.30
Baker, J.31
Stewart, J.P.32
Head-Gordon, M.33
Gonzalez, C.34
Pople, J.A.35
more..
-
21
-
-
0345135182
-
Structures of two active inotropic cardiac agents: Milrinone [5-cyano-2-methyl-(3,4′-bipyridin)-6(1H)-one] (I) and amrinone [5-amino-(3,4′-bipyridin)-6(1H)-one] (II)
-
Cody V. Structures of two active inotropic cardiac agents: milrinone [5-cyano-2-methyl-(3,4′-bipyridin)-6(1H)-one] (I) and amrinone [5-amino-(3,4′-bipyridin)-6(1H)-one] (II). Acta Crystallogr., Sect. C. 43:1987;1325.
-
(1987)
Acta Crystallogr., Sect. C.
, vol.43
, pp. 1325
-
-
Cody, V.1
-
22
-
-
0003633932
-
-
Tripos Inc., St. Louis, MO 62117
-
SYBYL, Version 6.3, Tripos Inc., St. Louis, MO 62117, 1996.
-
(1996)
SYBYL, Version 6.3
-
-
|